Cite
HARVARD Citation
Li, J. et al. (n.d.). 2111 A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC). European journal of cancer. pp. S366-. [Online].